Bone Biologics (BBLG) Preferred Shares (2016)
Bone Biologics (BBLG) has disclosed Preferred Shares for 1 consecutive years, with -$1.8 million as the latest value for Q4 2016.
- On a quarterly basis, Preferred Shares changed N/A to -$1.8 million in Q4 2016 year-over-year; TTM through Dec 2016 was -$1.8 million, a N/A change, with the full-year FY2016 number at -$1.8 million, changed N/A from a year prior.
- Preferred Shares was -$1.8 million for Q4 2016 at Bone Biologics.
- In the past five years, Preferred Shares ranged from a high of -$1.8 million in Q4 2016 to a low of -$1.8 million in Q4 2016.